Skip to main content
Clinical Trials/NCT02691195
NCT02691195CompletedPhase 4

Ultrasound-guided Serratus Plane Block for the Quality of Recovery After Modified Radical Mastectomy

Fujian Provincial Hospital1 site in 1 country72 target enrollmentStarted: March 15, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
72
Locations
1
Primary Endpoint
The quality of recovery

Study Overview

Brief Summary

Regional anesthesia improves quality of recovery after surgery in many studies. Ultrasound-guided serratus plane block is a novel technique which may be a viable alternative to current regional anesthetic techniques. This randomized, controlled trial is to examine the effects of ultrasound-guided serratus plane block anesthetic on the QoR after breast tumor resection.

Detailed Description

A total of 72 subjects (36 patients for each groups) were enrolled in this study. Patients were allocated to either the general anesthesia group (group control) or SPB (serratus plane block) + general anesthesia groups (group SPB) using randomized central computer-generated sequence software (SAS 19.0). The allocation ratio was 1:1 for the two groups. Group assignment was concealed by opaque sticking envelops. The major research content is to evaluate the quality of recovery using 40 questionnaire (QoR-40).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients of American Society of Anesthesiologists' (ASA) Physical Status class I-II scheduled for first modified radical mastectomy were included.

Exclusion Criteria

  • Patients with chronic ethanol
  • long-term use of psychotropic drugs (e.g. sedative drugs and antidepressant);
  • contraindications for serratus plane block including coagulopathy, infection at the puncture site;
  • unable to cooperate with this research due to cognitive impairment, psychopathy or not willing for the hospital follow-up;
  • administration of other test drugs or joining in other clinical study in 3 months before our study;
  • received radiotherapy or chemotherapy before surgery;
  • other conditions not allocated for this study out of the researchers' consideration.

Arms & Interventions

group control

Placebo Comparator

group control :Before induction of intravenous anesthesia, patients were received an ultrasound-guided serratus plane block, the serratus plane was injected with 0.9% Nacl 0.4ml/Kg.

Intervention: 0.9% Nacl (Drug)

group SPB

Experimental

group SPB:Before induction of intravenous anesthesia, patients were received an ultrasound-guided serratus plane block, the serratus plane was injected with 0.5% ropivacaine 0.4ml/Kg.

Intervention: Ropivacaine (Drug)

Outcomes

Primary Outcomes

The quality of recovery

Time Frame: at 24 hours after surgery

The primary outcome was the quality of recovery, which was assessed at 24 hours after surgery using a 40-item questionnaire (QoR-40).

Secondary Outcomes

  • Postoperative pain intensity(at postoperative hours 0.5, 1, 2, 4, 8 and 24)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yao Yusheng

Associate professor

Fujian Provincial Hospital

Study Sites (1)

Loading locations...

Similar Trials